Trails Edge Capital Partners, LP on AVTX, Oct 29, 2026

Trails Edge Capital Partners, LP now owns 5.2%, as a passive investor.

Date
Oct 29, 2026
Who
Trails Edge Capital Partners, LP
Fund
AVTX - Avalo Therapeutics
Stake
5.2% (2,803,761 shares)
Type of notice
Passive investor
Document number
0001493152-26-049273

Open the original document at the SEC →

We read this document automatically. If something looks wrong, the original is the one that counts.

Back to AVTX